 House of Lords |
Session 2005-06 Publications on the internet Science and Technology Committee Publications |
| Science and Technology - Fourth Report Here you can browse the report which was ordered by the House of Lords to be printed 7 December 2005.
The likely impact of a pandemic
CHAPTER 3: PREVENTION IS BETTER THAN CURE
CHAPTER 4: NIP A PANDEMIC IN THE BUD
Mitigating the effects: antiviral drugs
Information gathering and reporting Managing resources and manpower
CHAPTER 7: A LONG-TERM STRATEGY Regulation and "mock-up" dossiers
CHAPTER 8: CONCLUSIONS AND RECOMMENDATIONS
Appendix 1: Members and Declarations of Interest Appendix 5: Glossary and Acronyms
Recent Reports From The House Of Lords
Science And Technology Committee
Oral Evidence
Written evidence from the BVA Oral evidence (13 October 2005) Mr Richard Stubbins, Chair, Pandemic Planning Sub-Group, UK Vaccine Industry Group (UVIG); Dr Kevin Bryett, Managing Director, Chiron Vaccines; Dr John Wood, Principal Scientist, Virology, National Institute for Biological Standards and Control (NIBSC); Mr John Harrison, Influenza Therapy Manager, Roche Products Ltd Written evidence from UVIG Written evidence from Chiron Vaccines Written evidence from NIBSC Written evidence from Roche Products Ltd Oral evidence (25 October 2005) Mrs Jan Hutchinson, NHS Alliance; Professor Pat Troop, Chief Executive, Health Protection Agency (HPA); Professor Maria Zambon, Head of the National Influenza Laboratory and Deputy Director, Virus Reference Division, Centre for Infection, HPA; and Dr Nigel Lightfoot, Director, Emergency Response, HPA Written evidence from the NHS Alliance Oral evidence (25 October 2005) Professor Nigel Mathers, Chair, Research Group, Royal College of General Practitioners (RCGP); Dr Richard Jarvis, Consultant in Health Protection and Council Member, British Medical Association (BMA); Ms Lynne Young, Primary Care Lead, Royal College of Nursing; Professor David Menon, Intensive Care Society; Ms Helen Young, Executive Director of Nursing / Clinical Director, NHS Direct Written evidence from RCGP Written evidence from the Intensive Care Society Oral evidence (27 October 2005) Supplementary written evidence from the BMA Dr Klaus Stohr, Team Co-ordinator, WHO Global Influenza Programme Oral evidence (27 October 2005) Supplementary written evidence by Roche Products Ltd Ms Rosie Winterton MP, Minister of State for Health Services; Dr David Harper, Chief Scientist and Dr David Salisbury, Head of Immunisation, Department of Health (DH) Written evidence from DH Oral evidence (1 November 2005) Supplementary written evidence from DH Dr David Nabarro, Senior UN System Co-ordinator for Avian and Human Influenza, and Louise Fresco, Assistant Director-General, Food and Agriculture Organisation (FAO) Oral evidence (1 November 2005) Deputy Chief Constable Alan Goodwin, Chair, Emergency Procedures Committee, Association of Chief Police Officers; Mr Philip Selwood, Chair, Civil Emergencies Committee, Ambulance Services Association; Professor Sue Atkinson, Regional Director of Public Health for London; Mr Zyg Kowalczyk, Director, London Resilience Team Oral evidence (3 November 2005) Professor Jim Norton, Institute of Directors (IOD); Mr Kevin Hawkins, Director General, British Retail Consortium; Mr Alan Lacey, Regulatory Affairs Manager, J Sainsbury plc Letter from Professor Jim Norton, IOD Oral evidence (3 November 2005)
Written Evidence
Dr Peter Bailey Dr Alan Hay, World Influenza Centre Institute for Animal Health and Roslin Institute Research Councils UK The Royal Society Dr R L Salmon, Communicable Disease Surveillance Centre, Wales Wellcome Trust
Note: References in the text of the Report are as
follows:
|
 
| |
| © Parliamentary copyright 2005 | |